- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03284359
Use of Nudges To Enhance Enrollment in Critical Care Research
A Randomized Trial of Nudges To Enhance Enrollment in Critical Care Research
Difficulties enrolling patients in randomized clinical trials (RCTs) have long been recognized as a major barrier to successful evaluation of medical interventions. This is particularly problematic among intensive care unit (ICU) trials, of which more than one-third do not reach target enrollment. Under-enrollment and selective enrollment reduce RCTs' abilities to answer the research questions, thereby degrading the trials' scientific value and ethics.
Current evidence suggests that financial incentives can ethically increase study enrollment, but this approach can pose large up-front costs to researchers. However, several nonmonetary behavioral interventions, or nudges, may offer novel and easily scalable approaches to increase enrollment in RCTs.
The investigation team propose a 2-arm RCT in 10 ICUs at Penn to test the relative effectiveness of nudges on enrollment rates. Investigators hypothesize that a bundle of nudges during recruitment will increase enrollment rates compared to usual recruitment procedures will increase enrollment.
Investigators will enroll 182 critically ill patients' surrogate decision makers(participants) to engage in recruitment procedures for a simulated RCT comparing two mechanical ventilation weaning protocols among mechanically ventilated patients. Investigators will also measure participants' assessment of risk of the simulated trial after the informed consent process. This work will provide the first empirical evidence regarding the efficacy of inexpensive, scalable nudges to potentially augment enrollment and reduce costs of future clinical trials.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104-6006
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Surrogate decision-makers of patients who are:
- Patient and surrogate is 18 years of age or older
- Surrogate is English-proficient
- Patient is mechanically ventilated
- Patient is admitted to participating ICU
Exclusion Criteria:
Surrogate decision-makers of patients who are:
- Patient is receiving comfort care only
- Patient has anticipated extubation in the next 24 hours.
- Patient with tracheostomy.
- Bedside clinician declines patient participation.
- Surrogate decision maker not available to approach prior to patient being extubated.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pre-Consent Nudge Bundle
Arm 1 will be administered a novel pre-consent nudge bundle which incorporates several behavioral economic interventions within a brief survey.
Participants will subsequently be asked by the same research personnel to participate in a simulated randomized control trial (RCT) comparing two mechanical ventilation weaning protocols among mechanically ventilated patients.
Participants will receive the standard consent form followed by a risk assessment and demographic survey.
|
The pre-consent nudge bundle survey was developed by the study team and incorporates several behavioral interventions into a bundle of 5 types of nudges: (i) injunctive norms; (ii) descriptive norms; (iii) duty of reciprocity; (iv) self-prophecy; and (v) foot-in-the-door.
Injunctive norms involve the perception of what behavior is acceptable, while descriptive norms highlight what behaviors others are engaging in.
The duty of reciprocity is the sense that one should repeat pro-social behavior for which they have benefited from.
The foot-in-the-door nudge involves asking a participant to perform a small request which has a high consent rate followed by a larger request.
The bundle consists of six questions and one statement.
|
|
No Intervention: Standard Consent
Arm 2 will serve as the control arm.
Participants will be approached by the research personnel to participate in a simulated RCT comparing two mechanical ventilation weaning protocols among mechanically ventilated patients.
Participants will receive a standard consent form as detailed in the Study Instruments section.
Following the consent process participants will conduct the same risk assessment survey and demographic survey.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Consent Rate
Time Frame: Up to 96 hours
|
The primary outcome is consent rate for a simulated RCT.
This is an easily measurable binary outcome that has the potential for significant impact on future trial recruitment.
|
Up to 96 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Risk Assessment
Time Frame: Up to 96 hours
|
Secondarily we will quantitatively assess the participant's assessment of the risk of participating in the simulated RCT.
The risk assessment tool has been previously used in the assessment of risk perception of RCT participation in the setting of behavioral economic nudges.
The risk assessment will be used to evaluate participants' impressions of the risk of participating in the RCT using a Likert scale ranging from 1 (Not risky at all) to 7 (very risky), as well as 9 comparative questions, each of which asks whether a study procedure was riskier than another risky activity, such as talking on one's cell phone while driving.
|
Up to 96 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Katherine Courtright, M.D., M.S., University of Pennsylvania
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 828046
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingDecision Making | Neonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Istituto Clinico HumanitasRecruitingCritical Illness Myopathy | Critical Illness Polyneuropathy | Critical Illness PolyneuromyopathyItaly
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Assistance Publique - Hôpitaux de ParisEuropean Society of Intensive Care Medicine; French Society for Intensive Care and other collaboratorsRecruitingCritical Illness | Intensive Care Patients | Critical Illness Requiring Intensive Care - Sepsis | Critical Illness Requiring Intensive Care - Acute Brain Injury | Critical Illness Requiring Intensive Care - Major Surgery | Critical Illness Requiring Intensive Care - PolytraumaFrance
-
Boston Children's HospitalCompleted
-
Istanbul Medeniyet UniversityRecruiting
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Karolinska InstitutetNot yet recruitingPediatric Critical IllnessSweden
Clinical Trials on Pre-Consent Nudge Bundle
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; University of North Carolina,... and other collaboratorsCompleted
-
University of California, Los AngelesNational Institute on Aging (NIA); RANDEnrolling by invitationPre-Operative Testing for Cataract SurgeryUnited States
-
King's College LondonKamuzu Central Hospital; University Teaching Hospital, Lusaka, Zambia; Komfo... and other collaboratorsUnknownGastroschisisCanada, Ghana, Malawi, Tanzania, United Kingdom, Zambia
-
Royal College of Surgeons, IrelandRecruitingPostoperative Complications | Urinary Incontinence | Prostate Cancer | Radical ProstatectomyIreland
-
University of MinnesotaAgency for Healthcare Research and Quality (AHRQ)CompletedWound Infection Due to Staphylococcus Aureus | MRSA Infection of Postoperative WoundUnited States
-
University of PittsburghNational Institute on Aging (NIA)Not yet recruitingDementia | Postoperative Delirium (POD) | Postoperative Cognitive Decline | Perioperative Complications | Postoperative Neurocognitive Disorder | Major Adverse Cardiac and Cerebrovascular EventsUnited States
-
University of MinnesotaRecruitingSurgical Site Infections | Healthcare Associated Infections | Staphylococcus Aureus ColonizationUnited States
-
University of WashingtonGenentech, Inc.RecruitingPrimary Mediastinal Large B-Cell Lymphoma | Aggressive Non-Hodgkin Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise Specified | T-Cell/Histiocyte-Rich Large B-Cell... and other conditionsUnited States